Melanotan 2 promises a year-round tan from a peptide injection. The reality is more complicated. Real users get the tan, plus side effects most articles glance over: nausea, mole darkening that stays after the tan fades, blood pressure shifts, and in some men spontaneous erections that last hours. Here is the honest all-in-one: how it works, dosing, side effects, the tan timeline, and what to know before sourcing.
🔑 Key Takeaways
- Melanotan 2 (MT-2) is a synthetic analog of alpha-MSH (alpha-melanocyte-stimulating hormone). It binds melanocortin receptors and stimulates melanin (specifically eumelanin) production in the skin.
- It is non-selective across MC1R, MC3R, MC4R, and MC5R, which is why a single peptide produces tanning, appetite suppression, libido increase, and (in some men) spontaneous erections.
- Standard loading dose is 0.25 to 0.5 mg daily for 7 to 14 days, then 0.5 to 1 mg twice weekly for maintenance. Going higher than 1 mg in early weeks dramatically worsens nausea.
- Visible tanning starts at 2 to 3 weeks with UV exposure (sun or controlled tanning bed). Full bronze effect takes 6 to 8 weeks. The tan fades over 4 to 8 weeks once you stop.
- The most common side effects are nausea (30 to 65% of users), facial flushing, fatigue, and (in men) spontaneous erections. Most resolve over 1 to 2 weeks if dosing is conservative.
- The honest concern is mole darkening. Existing moles and freckles get noticeably darker. Whether this raises melanoma risk is unclear, but baseline skin photography and an annual full-body skin check by a dermatologist are reasonable.
- Melanotan 1 (afamelanotide) is FDA-approved for a rare condition. Melanotan 2 is unapproved in the US, UK, EU, and Australia. Buying it online is not technically illegal in most jurisdictions, but it is sold without medical oversight.
- Vendor quality is the biggest sourcing issue. A 2015 analysis found some products contained only 43% of the labeled melanotan-2. Verify HPLC purity reports and look for third-party COAs.
This page covers everything that matters about melanotan 2: the biology, the protocols that actually work, the side effects with their real frequencies, mole monitoring, the comparison to MT-1 and PT-141, and how to source it without getting a 50%-purity vial.
What Is Melanotan 2?
A synthetic short peptide that mimics one of your body's tanning hormones.
Melanotan 2 (MT-2, sometimes "Melanotan II") is a synthetic 7-amino-acid cyclic peptide developed at the University of Arizona in the late 1980s. It was originally explored as a treatment for skin cancer prevention through induced melanin production. The "induced tanning" effect (which would, in theory, protect against UV damage) became the side effect that turned MT-2 into a popular underground tanning compound.
Melanotan 2 at a Glance
- Length: 7 amino acids, cyclic peptide
- Parent compound: Alpha-melanocyte-stimulating hormone (alpha-MSH)
- Targets: Melanocortin receptors MC1R, MC3R, MC4R, MC5R (non-selective)
- Half-life: ~33 to 60 minutes (short)
- Route: Subcutaneous injection (gold standard); nasal spray sometimes used
- FDA status: Not approved for any human use
- Approved relative: Afamelanotide (Melanotan 1), FDA-approved 2019 for erythropoietic protoporphyria (a rare light-sensitivity disorder)
Why melanotan 2 produces more than a tan
The melanocortin receptor family does not just regulate pigmentation. The four receptors MT-2 binds are involved in different biology:
- MC1R: Located on melanocytes. Triggers eumelanin (the dark protective pigment) over pheomelanin (the red-yellow type). This is the tanning effect.
- MC3R: Hypothalamic, involved in energy homeostasis and appetite
- MC4R: Hypothalamic and central nervous system. Regulates appetite (satiety) and sexual arousal pathways
- MC5R: Sebaceous glands, exocrine function, immune modulation
A drug that hit only MC1R would just be a tanning compound. Melanotan 2 is non-selective, which is why a single injection can produce a tan, suppress appetite, increase libido, raise blood pressure, and (in men with sufficient receptor density) trigger spontaneous erections. PT-141 (bremelanotide), a related but MC4R-selective peptide, was developed specifically for the sexual arousal effect without the tanning.
How Melanotan 2 Works
It tells your skin to produce more eumelanin.
Your skin always has the capacity to tan. The pathway runs from UV exposure to alpha-MSH release to MC1R activation on melanocytes to melanin synthesis. People with red hair and very fair skin often have less responsive MC1R variants, which is why they burn instead of tan. Melanotan 2 substitutes for endogenous alpha-MSH, with much higher potency and longer signaling, which forces the melanin synthesis pathway to ramp up even in people whose endogenous response is weak.
The catch: melanin production still depends on UV light to fully express. Melanotan 2 alone, without sun or tanning bed exposure, produces a slight overall darkening (especially of moles and existing freckles) but not the dramatic bronze effect users expect from before-and-after photos. The intended protocol pairs melanotan 2 with controlled UV exposure: short sessions, gradual increase, with the peptide as the primer rather than the painter.
Melanotan 2 Benefits
What users actually get, with honest probabilities.
1. Tanning effect
The primary use case. With consistent dosing and modest UV exposure (10 to 15 minute sessions, 3 to 4 times per week), most users see noticeable darkening at 2 to 3 weeks. Full effect at 6 to 8 weeks. Skin tones that previously burned often tan instead. The tan looks like a base tan, not orange or fake. Once stopped, the tan fades over 4 to 8 weeks as skin cells turn over.
2. Appetite suppression
Through MC4R activation, melanotan 2 reduces appetite at moderate doses. The effect is unintentional for most users, but real. Bodybuilders sometimes use this during pre-show prep. Strength of the effect depends on dose and individual receptor sensitivity.
3. Libido and sexual arousal
The MC4R pathway is the same one PT-141 (bremelanotide) was developed to hit. Melanotan 2 produces libido increases in both men and women. In men, it commonly produces spontaneous erections lasting 30 minutes to several hours, especially in the first 1 to 2 hours after a dose. This can be desirable or extremely inconvenient depending on context.
4. Photoprotection
The biological logic that originally drove melanotan-2 development. More eumelanin in the skin should mean more UV absorption and less DNA damage from sun exposure. The data on this is mixed: melanin does provide some UV protection, but melanotan-2 has not been shown to reduce skin cancer risk in any controlled trial. Treating it as a sun damage prevention tool is overreach.
What it does not reliably do
- Cure vitiligo (some early enthusiasm; no consistent evidence)
- Replace sunscreen (the photoprotection is partial)
- Provide a permanent tan (it fades when you stop)
- Improve skin texture or aging (it pigments, it does not collagen-build)
Melanotan 2 Dosage
The dosing protocol is simple. Going off-protocol is where people get into trouble.
| Phase | Daily dose | Duration | UV exposure |
|---|---|---|---|
| Loading week 1 | 0.25 mg | 7 days | None or minimal |
| Loading week 2 | 0.25 to 0.5 mg | 7 days | Brief sun (5 to 10 min) or low-intensity bed |
| Loading weeks 3 to 4 | 0.5 to 1 mg | 14 days | 10 to 15 min UV, 3 to 4 times per week |
| Maintenance | 0.5 to 1 mg, 1 to 2 times weekly | Indefinite while desired | Maintain UV exposure 1 to 2 times per week |
| Stopping | 0 | 4 to 8 weeks for tan to fade | Sun protection important |
Dosing differences by gender and skin type
- Fair skin (Fitzpatrick I and II): Start lower (0.1 to 0.25 mg) and go slower. Side effects are more pronounced; tanning effect appears later.
- Medium skin (Fitzpatrick III and IV): Standard protocol works well.
- Darker skin (Fitzpatrick V and VI): Tanning effect is less dramatic since baseline melanin is already high. Lower doses needed.
- Women: Often use lower doses (0.25 mg) than men due to smaller body weight and higher MC4R sensitivity in some.
- Men: Higher doses (0.5 to 1 mg) may be needed for visible tanning, but spontaneous erection side effect is more pronounced at higher doses.
Reconstitution
Standard 10 mg melanotan-2 vial:
- Add 2 mL bacteriostatic water
- Final concentration: 5 mg/mL (or 5,000 mcg/mL)
- On a U-100 insulin syringe, 5 units (0.05 mL) delivers 250 mcg
- 10 units delivers 500 mcg, 20 units delivers 1 mg
- Refrigerate after reconstitution. Use within 30 days.
Melanotan 2 Before and After: The Real Timeline
What actually changes, week by week.
| Week | What changes | What does not change yet |
|---|---|---|
| Week 1 | Nausea (worst at injection, fades over 1 to 2 hours), facial flushing. In some men, spontaneous erections start. | No visible tanning yet. Mole/freckle darkening may start. |
| Week 2 | Nausea decreases as body adapts. Existing freckles and moles begin to darken. With UV exposure, skin starts to develop a slight tan. | Tan still subtle. Most beach photos do not yet show change. |
| Week 3 to 4 | Visible tanning is now obvious in mirror and photos. Side effects mostly resolved. Appetite reduction noticeable. | Tan still building. Areas with less UV exposure remain lighter. |
| Week 6 to 8 | Full bronze effect for most users. Tan is even, deeper than achievable with the same UV exposure alone. Existing moles are noticeably darker than before treatment. | If you stopped now, tan fades over 4 to 8 weeks; mole darkening is slower to reverse. |
| Months 3 to 6 (maintenance) | Stable bronzed skin with maintenance dose. Side effects rare. Sexual side effects recede with continued use in most. | Some users develop tolerance; effect plateaus or diminishes slightly. |
| Off-cycle (4 to 8 weeks) | Tan fades steadily. Original skin tone returns over 2 to 3 months. | Mole darkening can persist. Skin checks recommended. |
Melanotan 2 Side Effects
Almost every user gets at least one. Most are manageable.
| Side effect | Frequency | Onset | Duration | Management |
|---|---|---|---|---|
| Nausea | 30 to 65% (worst at high starting dose) | 15 to 60 min after injection | 2 to 4 hours | Inject before bed, low starting dose, antihistamine, hydration |
| Facial flushing | 50 to 60% | 30 to 90 min | 45 to 90 min | Cool environment, hydration; usually decreases with time |
| Spontaneous erections (men) | 50 to 85% | 1 to 2 hours | 30 min to 4 hours | Inject in evening, lower dose; usually decreases with adaptation |
| Appetite suppression | Variable, dose-dependent | Hours | Ongoing | Conscious nutrition, protein focus |
| Yawning, drowsiness | 30 to 50% | 1 to 2 hours | 1 to 2 hours | Time injection for evening |
| Mole/freckle darkening | Near-universal | 7 to 14 days | Persistent, slow to reverse | Baseline photography, dermatology checks |
| Cardiovascular (BP up 6 to 12 mmHg, HR up 8 to 15 bpm) | 40 to 60% at 0.5 to 1 mg | 90 to 120 min | 6 to 8 hours | Monitor, avoid if hypertension |
| Injection site reactions | Common but mild | Hours | 1 to 2 days | Rotate injection sites |
The serious concerns
- Priapism: Erections lasting more than 4 hours are a medical emergency. Rare but reported. Stop the peptide and seek emergency care.
- Posterior reversible encephalopathy syndrome (PRES): Single case reports. Severe headache, confusion, vision change. Stop and seek care immediately.
- Cardiac events: Reported in users with pre-existing cardiovascular disease. Avoid melanotan-2 if you have hypertension, arrhythmia, or cardiovascular history.
- New mole development: Some users develop new pigmented lesions. Whether these are higher-risk than baseline is unclear, but they warrant dermatology evaluation.
Melanotan 2 and Mole Monitoring
This is the part most articles skip.
Melanotan 2 darkens existing moles and freckles. It can also induce new pigmented lesions. The melanoma question is genuinely unclear: melanotan-2 has not been shown in controlled trials to cause melanoma, but it has not been shown not to either. Dermatologists who see melanotan-2 users report that distinguishing between drug-induced mole darkening and early melanoma is harder than usual, which complicates surveillance.
The minimum surveillance protocol
- Baseline full-body photography before starting, including focused photos of any moles you can see.
- Annual dermatology full-body skin check. Baseline check before starting, then at least once per year while using.
- Self-check monthly using the ABCDE criteria (asymmetry, border, color, diameter, evolution). Any new lesion or rapid change deserves a same-month dermatology visit.
- Lower threshold for biopsy. If your dermatologist hesitates on a lesion in a melanotan-2 user, biopsy is the safer call.
Who should not use melanotan 2
- Personal or strong family history of melanoma
- Many or atypical (dysplastic) moles
- Hypertension or cardiovascular disease
- Pregnancy or breastfeeding (no data, avoid)
- History of priapism or sickle cell trait
- Active skin cancer or precancerous lesions
Melanotan 2 vs Melanotan 1 vs PT-141 vs Afamelanotide
Four related peptides, distinct purposes.
| Peptide | Receptor selectivity | Best for | FDA status |
|---|---|---|---|
| Melanotan 1 (afamelanotide) | MC1R selective | Tanning and photoprotection. Cleaner side effect profile than MT-2. | FDA-approved (as Scenesse) for erythropoietic protoporphyria |
| Melanotan 2 (MT-2) | Non-selective (MC1R, MC3R, MC4R, MC5R) | Tanning plus libido and appetite suppression | Not approved |
| PT-141 (bremelanotide) | MC4R primarily | Sexual arousal in men and women | FDA-approved (as Vyleesi) for hypoactive sexual desire disorder in women |
| Afamelanotide (Scenesse) | MC1R selective, slow-release implant | Photoprotection in EPP patients | FDA-approved 2019 for EPP |
If you mostly want a tan with fewer side effects
Melanotan 1 is the better choice. It is MC1R-selective, so you get the pigmentation without the libido and appetite effects. Side effect profile is cleaner. The downside is that MT-1 is harder to source online and the tanning effect builds more slowly. See our melanotan 1 vs 2 comparison.
If you mostly want sexual arousal
PT-141 is the right choice. It hits MC4R without the tanning side effects. FDA-approved for women, used off-label by men. Cleaner profile than melanotan-2 for libido. See our PT-141 dosage guide.
If you want the multi-effect package
Melanotan 2 is the only peptide that hits all four melanocortin receptors. The tan plus libido plus appetite suppression "stack" is unique to MT-2. Just do not pretend the side effects are not real.
Where to Buy Melanotan 2
Sourcing is the biggest practical issue with melanotan-2.
Melanotan 2 is not FDA-approved and not legally sold for human use in the US, UK, EU, or Australia. It is sold by online "research peptide" vendors as an unapproved compound. The legal risk to buyers is generally low (possession is rarely prosecuted), but the quality risk is real. A 2015 analysis of melanotan-2 vials from various vendors found some products contained as little as 43% of the labeled dose. Underdosing leads to no effect; overdosing (from a vial that turns out to be more potent than labeled) magnifies side effects.
What to verify before buying
- HPLC purity report showing 98% or higher, dated within 12 months
- Mass spectrometry confirming the 7-amino-acid sequence (M+H around 1024 for melanotan-2)
- Batch-specific COA rather than a generic one repeated across orders
- Sterility testing for the lyophilized injectable form
- Vendor reputation on independent peptide forums (not just the vendor's own reviews)
For broader sourcing standards, see our peptide vendor guide, how to read a peptide COA, and our specific where to buy melanotan-2 online guide.
Frequently Asked Questions
Medical disclaimer. This article is informational only and does not replace individualized medical advice. Melanotan 2 is not approved by the FDA for any human use. Anyone considering use, especially those with cardiovascular disease, melanoma risk factors, atypical moles, or who is pregnant or breastfeeding, should consult a qualified healthcare provider. Baseline dermatology evaluation and annual skin checks are recommended for users.
